Last reviewed · How we verify

drops intilation (Otocerum®)

Hospital Clinic of Barcelona · FDA-approved active Small molecule

Otocerum is a cerumenolytic ear drop formulation designed to soften and facilitate the removal of impacted cerumen (earwax) from the external auditory canal.

Otocerum is a cerumenolytic ear drop formulation designed to soften and facilitate the removal of impacted cerumen (earwax) from the external auditory canal. Used for Impacted cerumen (earwax) removal in the external auditory canal.

At a glance

Generic namedrops intilation (Otocerum®)
SponsorHospital Clinic of Barcelona
Drug classCerumenolytic agent
ModalitySmall molecule
Therapeutic areaOtolaryngology
PhaseFDA-approved

Mechanism of action

The drops contain surfactants and emollients that penetrate and break down the lipid-protein matrix of impacted cerumen, reducing its adhesion to the ear canal wall and making it easier to remove mechanically or allow natural drainage. This non-invasive approach reduces the need for manual cerumen extraction procedures that can cause discomfort or trauma to the delicate ear canal epithelium.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results